chrisvoncsefalvay/vaers-outcomes huggingface dataset:
For the first 24 hours, I experienced extreme fatigue, body aches, flu like symptoms but milder than experienced after the first dose.  On Monday 9/27, I noticed subtle neurological symptoms start just like after the first vaccine with difficulty putting my arm to my mouth when brushing my teeth.  It increasingly got worse on 9/28 and I was having difficulty writing, my gait was off, dizziness and light headed, my chest began to hurt (inflammatory condition symptoms), fatigue continued., feeling like I was powering down, when I laid down dizziness was worse and felt like I was going to pass out...had to sleep sitting up, extreme weakness in my arms and legs, difficulty getting from a sitting position to a standing position and when I do I have to try to get my balance before taking steps or I am afraid I am going to fall.  I thought about going to the ER  mainly because of the chest pain but I decided to take the ibuprofen to see if that would help with the chest pain and it did.  I did not have all of the same symptoms as last time, I had less symptoms this time and they were short lived.  I had the symptoms for a week and a half and then it all subsided leaving me with my normal low thyroid symptoms of weak legs and fatigue.  However, the inflammatory symptoms have continued to linger with coming and going in waves to this day.  The neurological symptoms subsided in a week and I slowly started to improve after that and after a week and a half, it seemed to be over.  It seems just like after the first vaccine, my symptoms of low thyroid and inflammatory condition are exasperated due to the vaccine and in addition neurological symptoms also start to occur after the vaccine.  I did not report this with the first vaccine because I did not contribute these symptoms to the vaccine at first.  I had no idea why this was happening to me.  Then, when I discussed it with both my primary doctor and my endocrinologist and the ER doctor...they all thought it was a result of low thyroid symptoms.  I missed my second dose due to being in the hospital and was hesitant to get my second dose but after talking to my endocrinologist again about my symptoms and whether she thought it was a result of low thyroid levels, she said yes.  I decided then I would get my second dose and then experienced the same symptoms after the second dose only not as severe and not as long of period of time.  I do believe that the vaccine exasperates my signs and symptoms of low thyroid levels, inflammatory condition and triggers neurological issues to occur.
Patient received a dose of the vaccine that was under-diluted by 50%. The patient received a dose that was 200% of the recommended dose. Patient remained in the pharmacy for 40 minutes after vaccine was administered and had no adverse reactions during that time. Patient and parent were counseled on the error immediately after it was discovered. Patient and parent were counseled on potential adverse events. Will follow up with 24-48 hours for update.
After receiving my Flu shot, I now have pain in my shoulder and elbow when moving my left arm.
CHIEF COMPLAINT:   IPF, long term use of home O2, continual use @ 2liters. Onset last night of worsening sob and increased work of breathing. Frequent cough- white mucus. Sees pulmonary Doctor No fever, diabetic Recent surgery L ankle No h/o blood clots ,no anticoagulants   HISTORY OF PRESENT ILLNESS:     56-year-old male past medical history of atypical chest pain, chronic back pain, cough, type 2 diabetes,, hypertension, and idiopathic pulmonary fibrosis being followed by pulmonary for increasing shortness of breath and work of breathing.  Associated with dry cough.  No fever or chills reported.  No modifying factors reported other than being Covid positive.  He does use long-term home O2 at 2 L nasal cannula.  Sats in the low 90s.
A report has been received from a Health Professional concerning a 5 year old, Female subject, who had been receiving FLUMIST, (intranasal). FLUMIST started on an unknown date. The reporter stated that patient was inadvertently administered expired FLUMIST on 26-Nov-2013. No adverse reaction had occurred. The outcome of the event of expired FLUMIST is unknown. The report was considered to be non-serious.
Information has been received from a healthcare worker referring to unspecified patients of unknown age and gender. On unspecified dates, the patients received improperly stored doses of VAQTA (route, strength, lot#, expiration dates and doses were unknown) (incorrect product storage). No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
Patient called pharmacy 10/17/17 to notify RPh of adverse event she believes is associated with flu shot she received 10/2/17. Patient complains of arm pain in same area she received injection. She reports pain of 4-5 when not moving her arm and pain scale of 7-8 when she moves her arm to pick something up or move a blanket. When asked when the pain started, she reports not paying attention to when the pain actually started but says it has been getting worse. Patient reported taking ibuprofen to help with the pain.
Patient stated her arm was very sore the evening after her vaccine given on 10/9/20.  She woke up on 10/10/2020 and had a rash on her arm where the vaccine was given.  States the rash was red and hot but not itchy.  The pain on 10/11/2020 was slightly better (verified with her it was not shoulder pain but rather the muscle area of injection around the level of her armpit) but she still has a rash that is warm.  Has had body aches and muscle soreness/pain but she stated that she was able to move around a little more today (10/11/20).  She said she did not have a reaction to first pneumonia vaccine (Prevnar) last year.  She had called from home but plans to follow up with primary or urgent care regarding the rash and will let us know the outcome.
Information has been received from a male consumer who was vaccinated with hep b vaccine recombinant. Subsequently the pt experienced a severe reaction to the vaccine, the pt believes it was an autoimune response. Additional info has been requested.
This spontaneous report as received from a registered nurse refers to a large number of unspecified college students of unknown age. On unspecified dates, these college students had been vaccinated with all required doses of Hepatitis B vaccine (manufacturer unknown), could not rule out RECOMBIVAX HB (lot#, dose, strength, indication and anatomical location not reported). On unspecified dates and yet these college students were sero-negative in regarded to titer results for Hepatitis B. The outcome of sero-negative in regard to titer results for hepatitis b was unknown. Additional information has been requested.
pt had high pitched unconsolable crying from 12PM-1245PM then quieted but resumed 3PM-445PM when mom called MD; t99.5 ax; leg red @ site x 2d & tender; slept p/5PM & thru noc w/o problems; APAP given;
Pt was very anxious.  She received vaccine and was sitting in the waiting area post vaccine.  Her head fell backwards and husband saw this-he pushed her head forward and yelled for help.  When I got to the pt she was unconcious and unresponsive.  I tried to revive pt and she initially did not respond. We called 911.  I lifted her head and she started to gurgle and seemed like she was going to throw up.  She then came to.  When EMT arrived they checked vitals and blood sugar.  All was fine.  Pt refused any other help.  I spoke with pt today and she is fine
Patient came to office on 02/26/21 stating that her arm was having redness and swelling that was spreading.  Note area of right arm to have redness, swelling and bruising with measurement of 8 x 10 cm.  Pt denies pain or drainage.  Pt was seen by provider, advised to elevate arm and place cool compresses over the weekend, provider gave pt personal cell # to call with any concerns and office would contact her on Monday 03/01/21.  Pt contacted today and came to office and again was seen by provider.  Area not as reddened and has fading yellow/ brown bruising area.  Pt continues to deny pain, states it itches at times.
No adverse effects reported; Multiple patients were vaccinated with improperly stored VAQTA; This spontaneous report was received from a medical assistant concerning a patient of unknown age and gender. The patient's concurrent conditions and medical history, as well as concomitant medications, were not reported.  On 12-JUN-2019, the patient was vaccinated with an improperly stored dose of hepatitis a vaccine, inactivated (VAQTA) 25/0.5 (units not provided), lot # R018935, expiration date 05-SEP-2019, for prophylaxis (dose, route, anatomical site and frequency were not reported). The reporter stated that the vaccine had a temperature excursion of 34.2 F for 4 hours and 54 minutes, which was detected by a data logger. The vaccine had no previous temperature excursion and there were no adverse effects reported.  This is one of several cases from the same reporter.; Sender's Comments:  US-009507513-1907USA001174: US-009507513-1907USA004852: US-009507513-1907USA004853: US-009507513-1907USA004854: US-009507513-1907USA004855: US-009507513-1907USA004856: US-009507513-1907USA004857: US-009507513-1907USA004858: US-009507513-1907USA004859: US-009507513-1907USA004860: US-009507513-1907USA004861: US-009507513-1907USA004862: US-009507513-1907USA004863: US-009507513-1907USA004864: US-009507513-1907USA004865: US-009507513-1907USA004866: US-009507513-1907USA004867: US-009507513-1907USA004868: US-009507513-1907USA004869: US-009507513-1907USA004870: US-009507513-1907USA004872: US-009507513-1907USA004873: US-009507513-1907USA004874: US-009507513-1907USA004875: US-009507513-1907USA004876: US-009507513-1907USA004877: US-009507513-1907USA004878: US-009507513-1907USA004879: US-009507513-1907USA004880: US-009507513-1907USA004881: US-009507513-1907USA004882: US-009507513-1907USA004883: US-009507513-1907USA004884: US-009507513-1907USA004885: US-009507513-1907USA004886: US-009507513-1907USA004887: US-009507513-1907USA004888: US-009507513-1907USA004889: US-009507513-1907USA004890:
This spontaneous report was received from a medical technologist,  referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant therapies and drug or allergy reactions were not provided. On 11-OCT-2018, the patient was vaccinated with PROQUAD (rHA) lot number R015742, expiration date on 02-DEC-2019 (strength, dose, dose number and administration route were not reported), for prophylaxis. Concomitant therapies included a properly stored MERCK STERILE DILUENT (lot number and expiration date were not reported). No adverse effects were reported. The vaccine was exposure to a temperature excursion between 6 Fahrenheit (F) and 14 F for 14 hours, which was registered  by the data logger. There was not previous temperature excursion. This is one of three reports received from the same reporter. Sender's Comments:  US-009507513-1810USA007826.
Pt states his whole right arm was swollen, red & sore down to the elbow for 3 days following vaccination.  Did not see MD.
Pneumovax 12/03/02, 12/04/02 Upper left arm red, swollen, tender to touch. Not hot, No medical tx@ present. Pt preferred to not tx medically.
Severe diarrhea lasting 3 weeks prior to event. On day of event (8/14/21) suddenly collapsed. Found to be in a complete heart block that required a pacemaker. No prior history of any heart condition.
WHILE GIVING VARICELLA VACCINE PATIENT WAS SITTING ON THE CHAIR AND AND HE FAINTED AND PASSED OUT ON FLOOR ON FACE AND GOT SOME TREMOR . MEANWHILE VACCINE WAS GIVEN COMPLELTY BUT HE FAINTED WHILE I WAS STILL GIVING THE VACCINE. NEEDELE HAS BEEN REMOVED. THERE WAS A NURSE IN CLINIC NEXT TO PHARMACY AND ME CHECKED ON HIM AND FOUND HIS BLOOD PRESSURE WAS 80/60 VASOVAGAL RESPONSE CAUSED THIS. WE GAVE HIM WATER AND JUICE AND TOOK SOME REST IN PHARMACY UNTIL FEEL OK
On 7/2/21, received 2nd dose Moderna COVID vaccine. Symptoms of dyspnea, cough started within 5-7 days of vaccine. on 7/30/21 evaluated by PCP for continue dyspnea, cough, tachycardia with HR 131, BP 152/120. Started metoprolol; CXR normal. Then on 8/3/21 admitted for observation due to chest pain, ROE, tachycardia, presumed rhinovirus. Respiratory film array positive for RSV. He ruled out for DVT, cardiac markers WNL. Discharged with Decadron and albuterol MVI.  On 08/10/21 Readmitted for persistent tachycardia, tachycardia, tachypnea, fatigue, malaise with TTE showing EF 30%. Started on Lisinopril, spironolactone, furosemide.  On 08/18/21 developed hyperkalemia with Potassium 6.8; spironolactone and lisinopril. On 08/31/21 cardiology consult; metoprolol. Plan for angiogram
Patient exp adverse events on 12/6 night with having chills and stated din't check his temp. When he woke on 12/7 was light headed until the symptoms wore off. He stated since 12/7 afternoon around 4 pm he started to feel better and gain a appetite. Also stated he felt the same symptoms after the 1st dose Shingrix too couldn't recall the date.
Chills, fever, body aches, headache, back and leg pain that lasted 2 days.
cough; Initial information received on 02-Dec-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case involves a 46 years old male patient who experienced cough, while he received vaccine RABIES (HDC) VACCINE [IMOVAX RABIES] and while treated with HUMAN RABIES IMMUNOGLOBULIN [IMOGAM RABIES-HT].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  No concomitant therapies were given.   On 23-Nov-2019, the patient started taking IMOGAM RABIES-HT (HUMAN RABIES IMMUNOGLOBULIN) dosage unknown route unknown (with an unknown batch number) for Immunisation.  On 23-Nov-2019, the patient received a first dose of suspect RABIES (HDC) VACCINE lot number not reported via unknown route in unknown administration site and 2 other doses were administered on unknown dates for suspect RABIES (HDC) VACCINE.  Patient stated that he is received the Imogam and Imovax because he found a bat in his house.  On an unknown date, the patient developed a non-serious cough (Unknown latency) following intake of HUMAN RABIES IMMUNOGLOBULIN and unknown latency following the administration of RABIES (HDC) VACCINE.  Patient stated that he saw on some paperwork that Xrays may interact with Imovax Rabies or Imogam, and asked for any information on that. Patient had 2 chest Xrays after Imovax Rabies and Imogam, due to a cough.  (Other relevant tests included no laboratory data.)  Final diagnosis was cough.  It was not reported if the patient received a corrective treatment.  The patient outcome is reported as Unknown for cough.  There will be no information available on the batch number for this case (patient did not have it).
Rash on chest, headaches, swelling -mainly above left eye, feverish, weakness, some dizziness, difficulty breathing during exercise  (3 days after the flu shot).
This spontaneous report received from a registered nurse referred to a 4 year old patient of unknown gender. The patient's medical history, current conditions and concomitant medications were not reported. On 13-SEP-2016, the patient was vaccinated with M-M-R II (lot number: L036851), dose, frequency, expiry date were not reported) which was stored improperly. No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of the several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1609USA014830: same reporter US-009507513-1609USA013814: same reporter US-009507513-1610USA004339: same reporter.
Initially caused dizziness off and on for about 3 weeks.; Threw "me" into menopause; This is a spontaneous report from a non-contactable consumer, the patient. A 49-year-old, non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 30Apr2021 at 16:00 in the right arm (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included unspecified allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included multivitamins (MANUFACTURER UNKNOWN) started on an unknown date for an unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on unknown date as a single dose for COVID-19 immunisation. On an unknown date in 2021, the patient experienced dizziness off and on for about 3 weeks and stated that vaccine threw her into menopause. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events dizziness off and on for about 3 weeks was resolved on an unknown date in 2021; while that of the event menopause was not resolved at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Date of vaccine 12/7/2020-Patient had very sore painful left deltoid and had to take Tylenol pain level 7 out of 10 and interrupted sleeping. 2nd day-12/18/2020-Patient had left sided body weakness, pain at injection site, pain all on left side of body taking Motrin. On 3rd day symptoms all subsided and were gone. No fevers or chills during any symptoms.
Doctor ordered PEDIARIX and nurse administered KINRIX, she thought they were interchangeable.
Pt was given Hep A Adult but should have received Hep A Peds.
BILATERAL HAND ARTHRITIS, NO RX OTHER THAN NSAIDS, CONTINUES BUT BECOMING LESS SEVERE
pt recv vax 23MAY96 & 6DEC97 pt exp chickenpox & is covered w/lesions;it was reported that one of the pt sibling had a similar exp WAES97120573;
Slightly itchy rash progressing very slowy starting on my left arm (injection arm) and progressing to my right arm them torso, neck and chin area. The rash is still progressing a week after getting the injection.
Doses were administered after 12-hours in syringes; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses were administered after 12-hours in syringes) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses were administered after 12-hours in syringes). On 22-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Doses were administered after 12-hours in syringes) had resolved.            Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.
pt recvd MMR vax on 9SEP91 following exposure to a pt w/measles; on 18SEP91 pt felt achy all over exp @ back of neck in the cervical area; also devel t101 until 18SEP91; 20SEP91 pt noted a red, flat rash covering trunk & extremities;
pt dx w/infantile spasms in MAR93 by MD; sx @ the time were described as begining 2 months prev; 2 maternal cousins epileptic;
pt recvd vax;pt c/o pain in lt arm;weakness in lt hand p/ vax;23nov94 instructed to see MD;8dec94 sxs worse;unable to contact;
After receiving the second shot, i experienced joint pain, headache, chills, sweating and general feeling of malaise the day after (4/4/21)
Had a 20 sec deviation of the head to the left with eyes rolled up & not responsive. Then she was normal. No fever.
On April 26 I was feeling sore throat, chills, fevers, and aches. It was about 6 month from Moderna booster. I took a home test and it was positive. I contacted my Dr. and he suggested to get a antigen test to qualify for the antiviral. So I went to take the test on April 28th and qualified for antiviral. I did that at an urgent care. It lasted until May 1st.
This spontaneous report as received from a pharmacist refers to a 78 year old male patient. In 2013, the patient was vaccinated with ZOSTAVAX 19400 PFU (Lot# and exp date not reported) 0.65 ml, subcutaneous. No other co suspects were reported. No concomitant therapy was reported. The pharmacist reported that late January, early February, a few days after the patient developed a severe rash all over torso, arms and legs. Patient reported lesions and severe itching since the rash developed. The patient went to see physician three times, and no diagnosis was made. Treatment with anti-itch cream SARNA (manufacturer unknown) was prescribed. Lab diagnostics were not performed. The patient stated that the cream relieved itching for a few hours at a time. Rash has not currently resolved. The outcome of the patient developed a severe rash all over, torso, arms and legs was reported as not recovered/not resolved. Additional information has been requested.
slight jabbing pain on her left side; experiencing seasonal allergies; getting hoarse; a jabbing left side chest pain; diarrhea; felt a little tired; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (a jabbing left side chest pain), DIARRHOEA (diarrhea), PAIN IN EXTREMITY (slight jabbing pain on her left side), SEASONAL ALLERGY (experiencing seasonal allergies) and DYSPHONIA (getting hoarse) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension, Sulfonamide allergy, Drug allergy (codeine) and Seasonal allergy. Concomitant products included ATENOLOL, LOSARTAN, AMLODIPINE, CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) and MINERALS NOS, VITAMINS NOS (CENTRUM A TO ZINC) for an unknown indication.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced FATIGUE (felt a little tired). On 09-Mar-2021, the patient experienced CHEST PAIN (a jabbing left side chest pain) and DIARRHOEA (diarrhea). On 10-Mar-2021, the patient experienced PAIN IN EXTREMITY (slight jabbing pain on her left side), SEASONAL ALLERGY (experiencing seasonal allergies) and DYSPHONIA (getting hoarse). At the time of the report, CHEST PAIN (a jabbing left side chest pain), DIARRHOEA (diarrhea), PAIN IN EXTREMITY (slight jabbing pain on her left side), SEASONAL ALLERGY (experiencing seasonal allergies), DYSPHONIA (getting hoarse) and FATIGUE (felt a little tired) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: Event outcome updated.
patient states that when the vaccine was administered, he felt a sharp pain in his neck and as he walked out of the store his pinky and ring finger and the outside of his right hand went numb. He states that it does feel slightly better this morning
This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after published expiration date and 30 day BUD.) and NO ADVERSE EVENT (No adverse event) in a 47-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 074B22A) for COVID-19 prophylaxis.     Patient received unknown vaccine in the 4 weeks prior to COVID-19 vaccine.  Concomitant products included INFLUENZA VACCINE for an unknown indication.          For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Dose administered after published expiration date and 30 day BUD.).    Patient had no reported symptoms. No treatment information was provided by the reporter.